The 27 references in paper V. Dobronravov A., M. Khrabrova S., A. Mukhametdinova O., V. Sipovskiy G., В. Добронравов А., М. Храброва С., А. Мухаметдинова О., В. Сиповский Г. (2017) “ЧАСТОТА ВЫЯВЛЕНИЯ И ПРОГНОЗ АНТИТЕЛЬНООПОСРЕДОВАННОГО ОТТОРЖЕНИЯ ПРИ АЛЛОТРАНСПЛАНТАЦИИ ПОЧКИ // INCIDENCE AND PROGNOSIS OF ANTIBODY-MEDIATED REJECTION IN KIDNEY ALLOGRAFTS” / spz:neicon:nefr:y:2016:i:6:p:82-89

1
Haas M, Sis B, Racusen LC et al. Banff 2013 Meeting Report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14 (2): 272-283
(check this in PDF content)
2
Lefaucheur C, Loupy A, Vernerey D et al. Antibody mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013; 9863: 313-319
(check this in PDF content)
3
Orandi BJ, Chow EH, Hsu A et al. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant 2015; 15 (2): 489-498
(check this in PDF content)
4
Lionaki S, Panagiotellis K, Iniotaki A et al. Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol 2013; 2013: http://www. hindawi.com/journals/jir/2013/849835
(check this in PDF content)
5
Dörje C, Midtvedt K, Holdaas H et al. Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation 2013; 96 (1): 79-84
(check this in PDF content)
6
Böhmig GA, Regele H, Hörl WH. Protocol biopsies after kidney transplantation. Transpl Int 2005; 18 (2): 131-139
(check this in PDF content)
7
Yamamoto T, Watarai Y, Takeda A et al. De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury. Transplantation 2015; Epub ahead of print
(check this in PDF content)
8
Sellarés J, de Freitas DG, Mengel M et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12 (2): 388-399
(check this in PDF content)
9
Loupy A, Vernerey D, Tinel CJ et al. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. Am Soc Nephrol 2015; 26 (7): 1721-1731
(check this in PDF content)
10
Woodroffe R, Yao GL, Meads C et al. Clinical and costeffectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 2005; 9 (21): 1-179, iii-iv
(check this in PDF content)
11
Kyriakides G, Miller J. Use of cyclosporine in renal transplantation. Transplant Proc 2004; 36 (2 Suppl):167S-172S
(check this in PDF content)
12
Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9 (11): 2520-2531
(check this in PDF content)
13
Wiebe C, Gibson IW, Blydt-Hansen TD et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12 (5): 1157-1167
(check this in PDF content)
14
Papadimitriou JC, Drachenberg CB, Ramos E et al. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation 2013; 95 (1): 128-136
(check this in PDF content)
15
Yamanaga S, Watarai Y, Yamamoto T et al. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renaltransplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches. Hum Immunol 2013; 74 (9): 1111-1118
(check this in PDF content)
16
Halloran PF, Merino Lopez M, Barreto Pereira A.. Identifying subphenotypes of antibody-mediated rejection in kidney transolants. Am J Transplant 2016; 16 (3): 908-920
(check this in PDF content)
17
Halloran PF, Famulski KS, Chang J. A probabilistic approach to histologic diagnosis of antibody-mediated rejection in kidney transplant biopsies. Am J Transplant 2016; Jun 24: Epub ahead of print
(check this in PDF content)
18
Fotheringham J, Angel CA, McKane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009; 113 (1): c1-7
(check this in PDF content)
19
Drachenberg CB, Papadimitriou JC. Endothelial injury in renal antibody-mediated allograft rejection: a systematic view based on pathogenesis. Transplantation 2013; 95 (9):1073-1083
(check this in PDF content)
20
Nabokow A, Dobronravov VA, Khrabrova M et al. Longterm kidney allograft survival in patients with transplant glomerulitis. Transplantation 2015; 99 (2): 331-339
(check this in PDF content)
21
Храброва МС, Добронравов ВА, Набоков АВ и др. Микроваскулярное воспаление как прогностический фактор при трансплантации почки. Нефрология 2015; 19 (5): 34-41 [Khrabrova MS, Dobronravov VA, Nabokov AV i dr. Mikrovaskulyarnoe vospalenie kak prognosticheskiy factor pri transplantacii pochki. Nefrologiya 2015; 19 (5): 34-41]
(check this in PDF content)
22
Naesens M, Kuypers DR, De Vusser K et al. The histology of kidney transplant failure: a long-term follow-up study. Transplantation 2014; 98 (4): 427-435
(check this in PDF content)
23
Bagnasco SM, Zachary AA, Racusen LC et al. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation 2014; 97 (4): 440-445
(check this in PDF content)
24
Tsuji T, Yanai M, Itami H et al. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection. Nephrology (Carlton) 2015; 20 Suppl 2: 26-30
(check this in PDF content)
25
Miura M, Harada H, Fukasawa Y et al. Long-term histopathology of allografts in sensitized kidney recipients. Clin Transplant 2012; 26 Suppl 24: 32-36
(check this in PDF content)
26
Collaborative Transplant Study [Электронный ресурс]. Режим доступа: http://www.ctstransplant.org/public/graphics/ sample.shtml
(check this in PDF content)
27
Бикбов БТ, Томилина НА. Заместительная терапия больных с хронической почечной недостаточностью методами перитонеального диализа и трансплантации почки в Российской Федерации в 1998-2011 г. (Отчет по данным Российского регистра заместительной почечной терапии.
(check this in PDF content)